13F HOLDINGS REPORT
VR Adviser, LLC
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001104659-24-118950
Total Value
$1.91B
Positions
38
Other Managers
0
Confidential Omitted
No
Holdings (38)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APOGEE THERAPEUTICS INC | APGE | 8,493,321 | $498.9M | 26.13% |
| 2 | OCULAR THERAPEUTIX INC | OCUL | 12,762,462 | $111.0M | 5.82% |
| 3 | ENLIVEN THERAPEUTICS INC | ELVN | 4,026,331 | $102.8M | 5.39% |
| 4 | VIRIDIAN THERAPEUTICS INC | VRDN | 3,882,709 | $88.3M | 4.63% |
| 5 | APPLIED THERAPEUTICS INC | 03828A101 | 9,825,000 | $83.5M | 4.37% |
| 6 | SPYRE THERAPEUTICS INC | SYRE | 2,685,448 | $79.0M | 4.14% |
| 7 | DYNE THERAPEUTICS INC | DYN | 2,173,913 | $78.1M | 4.09% |
| 8 | ORUKA THERAPEUTICS INC | ORKA | 3,085,620 | $75.6M | 3.96% |
| 9 | KALVISTA PHARMACEUTICALS INC | KALV | 6,249,731 | $72.4M | 3.79% |
| 10 | PHARVARIS N V | PHVS | 3,395,606 | $62.9M | 3.29% |
| 11 | COGENT BIOSCIENCES INC | COGT | 5,684,167 | $61.4M | 3.22% |
| 12 | DIANTHUS THERAPEUTICS INC | DNTH | 1,744,373 | $47.8M | 2.50% |
| 13 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 4,400,000 | $47.6M | 2.49% |
| 14 | MERUS N V | N5749R100 | 907,963 | $45.4M | 2.38% |
| 15 | ORIC PHARMACEUTICALS INC | ORIC | 4,394,527 | $45.0M | 2.36% |
| 16 | ERASCA INC | ERAS | 16,216,216 | $44.3M | 2.32% |
| 17 | PRAXIS PRECISION MEDICINES I | PRAX | 706,131 | $40.6M | 2.13% |
| 18 | ASTRIA THERAPEUTICS INC | 04635X102 | 3,458,645 | $38.1M | 1.99% |
| 19 | TERNS PHARMACEUTICALS INC | TERN | 3,410,058 | $28.4M | 1.49% |
| 20 | AQUESTIVE THERAPEUTICS INC | AQST | 5,555,555 | $27.7M | 1.45% |
| 21 | EDGEWISE THERAPEUTICS INC | EWTX | 1,000,000 | $26.7M | 1.40% |
| 22 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 1,609,569 | $24.9M | 1.30% |
| 23 | ENGENE HOLDINGS INC | ENGNW | 3,565,841 | $23.5M | 1.23% |
| 24 | CULLINAN THERAPEUTICS INC | CGEM | 1,379,965 | $23.1M | 1.21% |
| 25 | MERSANA THERAPEUTICS INC | 59045L106 | 11,328,000 | $21.4M | 1.12% |
| 26 | TAYSHA GENE THERAPIES INC | TSHA | 9,000,000 | $18.1M | 0.95% |
| 27 | ABIVAX SA | AAVXF | 1,345,780 | $15.5M | 0.81% |
| 28 | TREVI THERAPEUTICS INC | TRVI | 3,422,656 | $11.4M | 0.60% |
| 29 | ARVINAS INC | ARVN | 454,450 | $11.2M | 0.59% |
| 30 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 1,467,048 | $10.3M | 0.54% |
| 31 | CENTURY THERAPEUTICS INC | IPSC | 5,389,259 | $9.2M | 0.48% |
| 32 | ZURA BIO LTD | ZURA | 2,023,166 | $8.2M | 0.43% |
| 33 | PERCEPTIVE CAP SOLUTIONS COR | G70077105 | 750,000 | $7.5M | 0.39% |
| 34 | CABALETTA BIO INC | CABA | 1,563,952 | $7.4M | 0.39% |
| 35 | CASI PHARMACEUTICALS INC | CASIF | 987,259 | $6.1M | 0.32% |
| 36 | TENAYA THERAPEUTICS INC | TNYA | 1,555,556 | $3.0M | 0.16% |
| 37 | INSTIL BIO INC | TIL | 33,177 | $2.2M | 0.12% |
| 38 | TENAX THERAPEUTICS INC | TENX | 208,333 | $720,832 | 0.04% |